Shell Asset Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
RG
PA
VPC
Shell Asset Management's ZYME Position: Q3 2025 in Review
Shell Asset Management reduced its Zymeworks (ZYME) stake by 55% in Q3 2025, selling an estimated $72.8K and leaving 4,212 shares worth $72K. The position accounts for 0.01% of the portfolio, ranked #757.
Shell Asset Management first reported a position in ZYME in Q2 2020 and has held it in 12 quarters since. The position peaked at $181K in Q4 2024. 183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.
- Shell Asset Management held 4,212 shares of Zymeworks worth $72K as of Q3 2025.
- Shell Asset Management sold 5,084 Zymeworks shares in Q3 2025, an estimated $72.8K.
- Zymeworks made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #757 holding.
- Shell Asset Management first reported a position in Zymeworks in Q2 2020 and has held it in 12 quarters since.
- Shell Asset Management's Zymeworks position peaked at $181K in Q4 2024.
- 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.